Supplemental material for Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial (2019)

First Author: Hans-Christoph Diener

Attributed to: MICA: Assessing the therapeutic efficacy of 11beta-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in idiopathic intracranial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.25384/sage.9862496

Publication URI: https://sage.figshare.com/articles/Supplemental_material_for_Non-invasive_vagus_nerve_stimulation_nVNS_for_the_preventive_treatment_of_episodic_migraine_The_multicentre_double-blind_randomised_sham-controlled_PREMIUM_trial/9862496

Type: Other